DUBLIN – The International Society for Cellular Therapies (ISCT) has added its voice to those opposing the Regrow Act, a bipartisan bill introduced in the Senate in March, which aims to speed development of regenerative medicine and restore what its sponsors regard as America's lost prominence in the field.